Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine and Neuroendocrine Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04134832
What this trial is testing

Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region

Who this might be right for
Pancreatic Neuroendocrine Tumor
University Hospital, Strasbourg, France 250
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Early research (Phase 1)Ended earlyNCT02711345
What this trial is testing

A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers.

Who this might be right for
Ovarian NeoplasmsNon-Small-Cell Lung CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT01824875
What this trial is testing

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+4 more
ECOG-ACRIN Cancer Research Group 144
Not applicableActive Not RecruitingNCT03285230
What this trial is testing

The French E3N Prospective Cohort Study

Who this might be right for
Breast CancerColo-rectal CancerParkinson Disease+11 more
Institut National de la Santé Et de la Recherche Médicale, France 100,000
Not applicableLooking for participantsNCT07328607
What this trial is testing

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

Who this might be right for
Pancreatic Ductal AdenocarcinomaAmpullary CarcinomaDistal Cholangiocarcinoma+2 more
Minia University 90
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Ended earlyNCT01886287
What this trial is testing

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Who this might be right for
Neuroendocrine Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT04205227
What this trial is testing

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

Who this might be right for
CancerMelanomaOvary Cancer+2 more
ENB Therapeutics, Inc 137
Early research (Phase 1)Study completedNCT00804336
What this trial is testing

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 22
Not applicableLooking for participantsNCT07389512
What this trial is testing

Pharmaceutical Management in Targeted Radioligand Therapy

Who this might be right for
CancerThyroid CancerMetastatic Prostate Cancer+1 more
Hospices Civils de Lyon 600
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Not applicableEnded earlyNCT02363647
What this trial is testing

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

Who this might be right for
Medullary Thyroid CancerColon Cancer
Icahn School of Medicine at Mount Sinai 10
Testing effectiveness (Phase 2)Study completedNCT00113360
What this trial is testing

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine CarcinomaIslet Cell Carcinoma
M.D. Anderson Cancer Center 67
Testing effectiveness (Phase 2)Ended earlyNCT03042780
What this trial is testing

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorPancreatic CancerNeuroendocrine Carcinomas of Pancreas+1 more
H. Lee Moffitt Cancer Center and Research Institute 2
Post-approval studies (Phase 4)Active Not RecruitingNCT01896479
What this trial is testing

Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Exelixis 247
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05316480
What this trial is testing

Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms

Who this might be right for
Pancreatic Neuroendocrine Neoplasm
Fudan University 42
Not applicableStudy completedNCT03174574
What this trial is testing

Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.

Who this might be right for
Pancreas CancerMelanoma
Mayo Clinic 3
Not applicableLooking for participantsNCT04949282
What this trial is testing

Spanish Series of Patients Treated With the Radionuclide Lutetium177

Who this might be right for
Neuroendocrine TumorsIntestinal NeoplasmsPancreatic Neoplasms+15 more
Sociedad Española de Medicina Nuclear e Imagen Molecular 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Next Page